Provided by Tiger Trade Technology Pte. Ltd.

Xenon Pharmaceuticals

36.56
+0.40001.11%
Volume:569.37K
Turnover:20.70M
Market Cap:3.53B
PE:-7.77
High:36.70
Open:36.05
Low:35.98
Close:36.16
52wk High:72.66
52wk Low:35.06
Shares:96.64M
Float Shares:95.45M
Volume Ratio:0.35
T/O Rate:0.60%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.7061
EPS(LYR):-4.3646
ROE:-43.62%
ROA:-28.02%
PB:2.84
PE(LYR):-8.38

Loading ...

Xenon Pharmaceuticals Signals Strong Momentum In Earnings

TIPRANKS
·
May 20

A Look At Xenon Pharmaceuticals (XENE) Valuation After Phase III Azetukalner Milestones And Extended Cash Runway

Simply Wall St.
·
May 14

Xenon Pharmaceuticals Is Maintained at Overweight by JP Morgan

Dow Jones
·
May 12

Xenon Pharmaceuticals price target raised to $80 from $77 at JPMorgan

TIPRANKS
·
May 12

Xenon (XENE) Gets a Buy from Stifel Nicolaus

TIPRANKS
·
May 11

Xenon Pharmaceuticals price target raised to $69 from $68 at Wells Fargo

TIPRANKS
·
May 10

Wells Fargo Remains a Buy on Xenon (XENE)

TIPRANKS
·
May 10

Xenon Pharmaceuticals price target lowered to $78 from $80 at Needham

TIPRANKS
·
May 09

Xenon Pharmaceuticals Is Maintained at Buy by Needham

Dow Jones
·
May 08

Needham Reaffirms Their Buy Rating on Xenon (XENE)

TIPRANKS
·
May 08

H.C. Wainwright Remains a Buy on Xenon (XENE)

TIPRANKS
·
May 08

Xenon Pharmaceuticals Q1 Loss Widens

MT Newswires Live
·
May 08

Earnings Flash (XENE) Xenon Pharmaceuticals Posts Q1 Per Share Loss $1.17, vs. FactSet Est of Loss $1.18

MT Newswires Live
·
May 08

Xenon Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 08

Canada's Xenon reports Q1 net loss slightly better than expected

Reuters
·
May 08

Xenon Pharmaceuticals Q1 EPS $(1.17) Beats $(1.20) Estimate, Cash, Cash Equivalents And Marketable Securities Of $1.3B Extends Cash Runway Into 2029

Benzinga Earnings
·
May 08

Xenon Q1 net loss widens to $102.3 million; R&D expenses climb to $88.5 million

Reuters
·
May 08

BRIEF-Xenon Pharmaceuticals Q1 Net Income USD -102.302 Million Vs. IBES Estimate USD -102.8 Million

Reuters
·
May 08

Xenon Pharmaceuticals Q1 Operating Expenses USD 112.328 Million

THOMSON REUTERS
·
May 08

Xenon Reports Q1 2026 Financial Results and Provides Business Update

THOMSON REUTERS
·
May 08